NAFDAC Issues Recall For Deekins Amoxycillin 500mg Capsule Batch

NAFDAC Issues Recall For Deekins Amoxycillin 500mg Capsule Batch

The National Agency for Food and Drug Administration and Control (NAFDAC) has informed the public about the recall of a specific batch of Deekins…READ MORE…

Amoxycillin 500mg Capsules, produced by Ecomed Pharma Ltd and distributed by DevineKings Pharmaceutical Ltd, with lot number 4C639001.

According to a report published on its website, which was also obtained by Vanguard, this recall is prompted by reports of severe adverse drug reactions associated with this batch.

Ecomed Pharma Ltd has stated that a hospital documented three serious adverse reactions in patients who were administered this batch of Deekins Amoxycillin 500mg Capsules.

Amoxicillin, a penicillin antibiotic, is typically used to treat bacterial infections such as tonsillitis, bronchitis, sinusitis, pneumonia, and infections of the ear, nose, throat, skin, or urinary tract.

NAFDAC cautioned that adverse reactions to medications could be life-threatening and may necessitate hospitalization, extend existing hospital stays, lead to significant disabilities or incapacitation, cause birth defects, or result in fatalities. The details of the affected product are as follows: Name: MAH, manufactured by Ecomed Pharmaceutical Ltd; Manufacturing Date: 03/2024; Expiry Date: 02/2027; Batch Number: 4C639001.

The agency has urged distributors, healthcare providers, and patients to remain vigilant throughout the supply chain to prevent the distribution and use of the affected lot.

“All medical products must be sourced from authorized or licensed suppliers. Careful checks on the authenticity and physical condition of these products are essential.”

Those in possession of the affected lot are advised to halt sales or use immediately and return their stock to the nearest NAFDAC office.

If anyone has used this product, or knows someone who has, and experienced any adverse reactions, they should seek immediate medical advice from a qualified healthcare professional.

Healthcare professionals and consumers are encouraged to report any suspicions of substandard or counterfeit medications to the nearest NAFDAC office or contact NAFDAC at 0800-162-3322 or via email at [email protected].

NAFDAC also encourages healthcare professionals and patients to report any adverse events or side effects associated with the use of this medicinal product either to the nearest NAFDAC office or through the E-reporting platforms available on the NAFDAC website.

For More Information And News Update, Join Ireporteronline WhatsApp Channel With Link Below: https://whatsapp.com/channel/0029VaV4jB6DuMRgwqnJCF32 For advertisement inquiries only, kindly send a message to 09010649814 on Whatsapp